Keywords: avicena, progress, pd-02, minocycline, drugmaker, reported, encouraging

Avicena to progress PD-02 and minocycline

Article | 20 March 2006

Print This

US drugmaker Avicena has reported encouraging results from a Phase II study designed to evaluate its proprietary drug candidate, PD-02, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in